Eli Lilly Board Member Trades $229K In Company Stock

3 days ago · Eli Lilly Board Member Trades $229K In Company Stock. Disclosed in the latest SEC filing, a significant insider purchase on November 20, involves Kimberly H Johnson, Board …

CouponFollow Extension

$229
OFF

Eli Lilly Board Member Trades $229K In Company Stock

5 days from now

3 days ago · Eli Lilly Board Member Trades $229K In Company Stock. Disclosed in the latest SEC filing, a significant insider purchase on November 20, involves Kimberly H Johnson, Board …

benzinga.com

56%
OFF

Eye On Growth: Gabrielle Sulzberger Adds $229K Of Eli Lilly Stock …

5 days from now

3 days ago · Eli Lilly shares are trading down 1.56% at $741.66 at the time of this writing on Thursday morning. Discovering Eli Lilly: A Closer Look Eli Lilly is a drug firm with a focus on …

benzinga.com

$231
OFF

Ralph Alvarez Boosts Confidence With $231K Purchase Of Eli Lilly …

5 days from now

2 days ago · A notable insider purchase on November 20, was reported by Ralph Alvarez, Board Member at Eli Lilly (NYSE:LLY), based on the most recent SEC filing.What Happened: In a …

nasdaq.com

$229
OFF

LLY Stock Price | Eli Lilly & Co. Stock Quote (U.S.: NYSE)

5 days from now

2 days ago · Eli Lilly Board Member Trades $229K In Company Stock Nov. 21, 2024 at 10:03 a.m. ET on Benzinga.com Insider Confidence On Display: Juan R Luciano Acquires $234K In Eli …

marketwatch.com

$454.15
OFF

Eli Lilly (NYSE:LLY) Stock, Insider Trading Activity - Benzinga

5 days from now

Eli Lilly (NYSE:LLY) Stock, Insider Trading Activity. ... Eli Lilly And Company Form4 Filing Shows LILLY ENDOWMENT INC Sold 27,353 Shares At An Average Price Of $454.15/Share.

benzinga.com

FAQs about Eli Lilly Board Member Trades $229K In Company Stock Coupon?

Why is Eli Lilly (LLY) stock down?

Eli Lilly and Company (LLY) stock is down in Wednesday's premarket trading after the pharmaceutical company reported third quarter results that missed revenue expectations. The disappointing performance was driven by lower-than-anticipated sales of the company's weight loss drug, Zepbound. ...

Is Eli Lilly a company?

Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes. How have LLY shares performed this year? How were Eli Lilly and Company's earnings last quarter? Does Eli Lilly and Company have any subsidiaries? ...

Where is Eli Lilly & Co headquartered?

The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN. LLY | Complete Eli Lilly & Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

What is Eli Lilly & Company EBITDA?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EBITDA is 15.04 B, and current EBITDA margin is 34.73 %. See more stats in financial statements How to buy Eli Lilly and Company stocks? ...

Is Eli Lilly a good stock to buy?

Eli Lilly and Company scored higher than 95% of companies evaluated by MarketBeat, and ranked 88th out of 1,014 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Earnings and Valuation 3.1 / 5Proj. Earnings Growth45.36% ...

Is Eli Lilly stock tanking?

Stocks are tanking. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology. Transparency is our policy. ...